CLINICAL_TRIALS
trial_result
· 2017-11-14
Clinical Trial Update: Clinical Study to Test a New Drug to Treat Major Depression [Phase 2]
Summary
Phase 2 clinical trial sponsored by GlaxoSmithKline tested a new antidepressant for major depressive disorder; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED | Results posted: 2017-11-14